Yabao Pharmaceutical Group Co., Ltd (SHA:600351)

China flag China · Delayed Price · Currency is CNY
6.08
-0.10 (-1.62%)
Jun 11, 2026, 11:29 AM CST
Market Cap4.28B -0.0%
Revenue (ttm)2.20B -13.1%
Net Income319.41M +34.4%
EPS0.46 +38.1%
Shares Out 692.00M
PE Ratio13.47
Forward PEn/a
Dividend0.30 (4.90%)
Ex-Dividend DateFeb 6, 2026
Volume4,168,300
Open6.14
Previous Close6.18
Day's Range6.04 - 6.18
52-Week Range5.86 - 8.68
Beta0.06
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About SHA:600351

Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, women's health products, patches, and general health products. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Beijing, China. [Read more]

Sector Healthcare
Founded 1978
Employees 3,415
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600351
Full Company Profile

Financial Performance

In 2025, SHA:600351's revenue was 2.24 billion, a decrease of -16.60% compared to the previous year's 2.69 billion. Earnings were 320.01 million, an increase of 31.86%.

Financial Statements